Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer
Titel:
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer
Auteur:
Harter, Philipp Bogner, Gerhard Chiva, Luis Cibula, David Concin, Nicole Fotopoulou, Christina Gonzalez-Martin, Antonio Guyon, Frederic Heinzelmann-Schwarz, Viola Kridelka, Frederic Mahner, Sven Marmé, Frederik Marth, Christian Morice, Philippe Novák, Zoltán Papadia, Andrea Ray-Coquard, Isabelle Redecha, Mikuláš Redondo, Andres Schwameis, Richard Sehouli, Jalid Undurraga, Manuela Van Gorp, Toon Vergote, Ignace